| A prospective, open, randomized, multicenter, controlled group study to assess the safety and efficacy of Navigator™ versus conventional care in post-operative cardiac surgery patients while undergoing coronary bypass grafting and/or heart valve repair or replacement while utilizing heart lung perfusion pump (The Nav-1 Study) |
| Location |
Multicentre - ICUs of six tertiary Australian hospitals |
| Objective |
To test the efficacy and safety of targeted hemodynamic bedside care using a novel computer-based guidance system (Navigator™) for the circulation |
| Recruitment |
Closed. 112 patients; 59 in guided care arm, 53 in conventional therapy arm |
| Status |
Completed. |
| Results |
Guided hemodynamic therapy with the Navigator™ device was safe and non-inferior to standard ICU therapy. | |